Sandbox leucocytosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 382: Line 382:
:** The tumour cells are the ''sky''
:** The tumour cells are the ''sky''
|-
|-
| rowspan="7" |T cell lymphoma
| rowspan="6" |T cell lymphoma
|[[T-cell granular lymphocytic leukemia]]
|[[T-cell granular lymphocytic leukemia]]
|
|
Line 390: Line 390:
** Mitogen-activated proteinkinase/extracellular signal-regulated kinase (MAPK/ERK)
** Mitogen-activated proteinkinase/extracellular signal-regulated kinase (MAPK/ERK)
|
|
Symptoms of T-cell large granular lymphocyte leukemia may include the following:
Symptoms of T-cell large granular lymphocyte leukemia may include the following:
* Generalised weakness and [[Fatigue (physical)|fatigue]]
* Generalised weakness and [[Fatigue (physical)|fatigue]]
Line 426: Line 425:
|
|
|
|
|
* Cutaneous manifestaions
|
|
|-
|[[Peripheral T-cell lymphoma]],
|
|
|
|
|
|
|
|

Revision as of 16:41, 29 August 2018

  • Leukocytosis is defined as an elevated white blood cell (WBC) count greater than 11,000 per mm3 (11.0 × 109 per L).
  • The most common type of leukocytosis is neutrophilia.
    • Neutrophilia can be defined as an increase in the absolute number of mature neutrophils to greater than 7,000 per mm3 [7.0 × 109 per L].
Differentiating Symptoms Differentiating physical exam findings Differentiating Labs
Physiological variation Birth
Adult
Pregnancy
Primary Congenital Heridatary neutrophilia
Chronic idiopathic neutrophilia
Down syndrome
LAD
Acquired CML
Polycythemia Vera
Secondary Infection Acute
Chronic
Connective tissue disorders RA
JRA
IBD
Chronic hepatitis
Drug induced Steriod
Lithium
Beta agonists
Cytokines
Marrow stimulation Hemolytic anemia
Immature thrombocytopenia
Post splenectomy
Metabolic Diabetic coma
Acidosis
Thyroid strom
Acute Gout
Seizures
Pathophysiology Symptoms History Physical Examination Laboratory Findings
Immunochemistry Blood work Biospy
B cell lymphoma Mantle cell lymphoma
  • Stage IV disease
  • B symptoms,
  • Generalized lymphadenopathy
  • Abdominal distention
  • Fatigue
  • Extranodal involvement of gastrointtestinal (GI) tract, lungs, and central nervous system (CNS)
  • History of Night sweats
  • Weight Loss
  • Generalized lymphadenopathy
  • Hepato-splenomegaly
  • Mental Retardation
  • Less commonly
    • Palpable masses in skin, breast, and salivary glands
  • CD5+
  • B-cell antigen positive
    • CD19
    • CD20
    • CD22
  • Cyclin D1 is overexpressed.
CBC
  • Anemia and cytopenias are secondary to bone marrow infiltration
  • Lymphocytosis > 4000/µL
  • Elevated LDH
  • Germinal centers filled by small-to-medium atypical lymphocytes.
  • Nodular appearance may be evident from expansion of the mantle zone in 30-50% of patients early in the disease.
Nodal marginal zone B-cell lymphoma
  • Arise from memory B cells. Include
    • Splenic marginal zone lymphoma
    • Nodal marginal zone lymphoma
    • Extranodal marginal zone lymphoma.
  • Stimulation of antigen receptor by autoantigen and co-stimulatory molecule CD40.
  • Depends largely on its location
  • Gastric marginal zone lymphoma
    • Dyspepsia
    • Abdominal pain
    • Hemorrhage
  • Chronic infectious conditions or autoimmune processes, such as
    • H pylori gastritis
    • Hashimoto thyroiditis
    • Sjögren syndrome.
  • AE1/AE3
  • B-cell markers CD20, CD79a, CD10, CD23, and bcl-2 are expressed
  • Follicular cells in reactive zone
  • Centrocyte like cells in marginal zone lymphoma
Splenic marginal zone lymphoma
  • Clonal rearrangements of the immunoglobulin genes (heavy and light chains) .
    • Deletion 7q21-32
    • Translocations of the CDK6 gene located at 7q21.
  • B-cells replace the normal white pulp of the spleen.
  • The neoplastic cells compromise
  • Sinus invasion
  • Epithelial histocytes
  • Plasmacytic differentiation of neoplastic cells.
  • Splenic Hilar Lymph Nodes
  • Bone Marrow Biopsy
    • Splenic marginal zone lymphoma in bone marrow displays a nodular pattern with morphology similar to what is observed in the splenic hilar lymph nodes.
Hairy cell leukemia
  • Production of cytokines, such as TNF alpha and IL-2R, provide important stimuli for malignant B cells proliferation in hairy cell leukemia.
    • The p38-MAPK-JNK cascade
    • The MEK-ERK cascade
    • The Phosphatidylinositol 3 kinase (PI3K)-AKT cascade
  • Review occupational history related to sawdust exposure
  • Review any exposure to radiations
  • Review any exposure to herbicides or diesel
  • Tartrate-resistant acid phosphatase positive
  • CBC
  • Small cells with "fried egg"-like appearance
  • Well-demarcated thread-like cytoplasmic extensions
  • Clear cytoplasm
  • Central round nucleus
  • Peri-nuclear clearing ("water-clear rim" appearance)
Plasma cell myeloma
Diffuse large B-cell lymphoma
  • Germinal centre B-cell-like (GCB)
  • Activated B-cell-like (ABC).
    • B cell receptor (BCR) signalling
    • B cell migration/adhesion
    • Cell-cell interactions in immune niches
    • Production and class-switching of immunoglobulins
  • Neutropenia
  • Anemia
  • Hypergammaglobulinemia

Centroblastic

Immunoblastic::

  • > 90% immunoblasts
  • Trapezoid shaped large lymphoid cells with significant basophilic cytoplasm

Anaplastic:

  • Very large cells with a round, oval, or polygonal shape that may resemble Reed-Sternberg cells of Hodgkin's lymphoma or Anaplastic Large cell Lymphoma.
Burkitt lymphoma
  • Translocation of chromosome 8 myc locus with 3 possible partners (accounting for 90% of translocations):
    • The Ig heavy chain region on chromosome 14: t(8;14)
    • The kappa light chain locus on chromosome 2: t(2;8)
    • The lambda light chain locus on chromosome 22: t(8;22)
  • Medium-sized (~1.5-2x the size of a RBC) with uniform size ("monotonous") -- key feature (i.e. tumor nuclei size similar to that of histiocytes or endothelial cells)
  • Round nucleus
  • Small nucleoli
  • basophilic cytoplasm
  • Brisk mitotic rate and apoptotic activity
  • Cellular outline usually appears squared off
  • "Starry-sky pattern":
    • The stars in the pattern are tingible-body macrophages (macrophages containing apoptotic tumor cells)
    • The tumour cells are the sky
T cell lymphoma T-cell granular lymphocytic leukemia
  • Disregulation of signaling pathways:
    • FAS/FAS-L
    • Phosphatidylinositol-3 kinase (PI3K),
    • Mitogen-activated proteinkinase/extracellular signal-regulated kinase (MAPK/ERK)

Symptoms of T-cell large granular lymphocyte leukemia may include the following:

  • Neutropenia
  • Anemia
  • Hypergammaglobulinemia
  • Clonal rearrangements of the T-cell receptor (TCR) gene
  • Chronic (> 6 months) elevation in large granular lymphocytes (LGLs) in the peripheral blood
  • Large granular lymphocyte count greater than 2.0 × 109/L
  • Lymphocytosis (typically 2-20x109/L)
Mycosis fungoides / Sézary syndrome
  • Cutaneous manifestaions
Subcutaneous panniculitis-like T-cell lymphoma
Enteropathy-type intestinal T-cell lymphoma
Anaplastic large cell lymphoma
Aggressive NK-cell leukemia

Differential diagnosis of Lymphocytosis

Pathophyisiology Symptoms History Physical Examination Laboratory Findings
AML
  • Mutation of myeloblast freezes the cell in its immature state and prevent differentiation.
  • Persistent or frequent infections.
  • Anemia leads to fatigue, paleness, and shortness of breath.
  • Thrombocytopenia leads to bruising or bleeding with minor trauma.
  • Bone tenderness
  • Skin manifestations
  • Immature Myeloblasts on blood smear
  • Flow cytometry
  • +Aur Rods
ALL
  • Arrest of lymphoblasts.
  • Chromosomal translocations involved
    • 9 and 22, t(9;22) (q34;q11.2) BCR-ABL1
    • 12 and 21, t(12;21)(p13;q22) TEL-AML1
    • 5 and 14, t(5;14)(q31;q32)IL3-IGH
    • 1 and 19 t(1;19)(q23;p13.3) TCF3-PBX1  
  • History of cancer
  • History of drug exposure
CML
  • Myeloproliferative expansion of pluripotent stem cells.
  • Philadelphia chromosome resulting from the reciprocal t(9;22)(q34;q11.2)
    • Resulting in a derivative 9q+ and a small 22q-. results in a BCR-ABL fusion gene
    • Ativates numerous downstream targets including
      • c-myc
      • Akt
      • Jun,
  • Insidious in onset
  • Nonspecific symptoms of fatigue and weight loss.
  • Early satiety and decreased food intake due to splenic compression of stomach
  • Low-grade fever and excessive sweating
  • Splenomegaly
    • Correlates with granulocyte counts
  • Findings of leukostasis and hyperviscosity.
  • Funduscopy may show papilledema, venous obstruction, and hemorrhages.
  • WBC counts, exceeding 300,000-600,000 cells/μL
  • Elevated alkaline phosphatase (ALP)
  • Philadelphia (Ph1) chromosome\
CLL
  • Review family history for members with positive history of the disease
  • Review occupational history related to farming
  • Review any exposure to herbicides or insecticides
  • Monoclonality of kappa and lambda producing B cells
  • Presence of smudge cells
Pathophysiology Symptoms History Physical Examination Laboratory Findings
CBC Blood smear Immunophenotype
Monoclonal B lymphocytosis
  • Monoclonal population of B lymphocytes <5000 cells/microL
  • Without other features of
    • Lymphadenopathy
    • Organomegaly
    • Extra-medullary involvement
  • Active or prior infections
  • History of hematologic malignancy
  • Medications
  • Family history of chronic lymphocytic leukemia (CLL)
  • Fever
  • Lymphadenopathy
  • Hepatosplenomegaly
  • Joint redness
  • Abdominal pain
  • Lung findings.
  • Lymphocytosis ≥4000 lymphocytes/microL
  • Lymphocytes in MBL have no distinguishing appearance
  • Appear as small, mature mononuclear cells.
  • CD19, CD20, and CD23
  • Does not require bone marrow examination or imaging for diagnosis
Congenital B cell lymphocytosis
Large granular lymphocyte leukemia
  • T-cell (T-LGL)
  • Natural killer cell (NK-LGL)
  • Recurrent infections
  • Fever
  • Night sweats
  • Unintended weight loss
  • Lymphadenopathy
  • Pancytopenia
  • Splenomegaly
  • CD3, CD57, CD56
  • CD3-, CD56+
Chronic lymphocytic leukemia
Sezary syndrome
Mantle cell lymphoma
Follicular lymphoma
Splenic marginal zone lymphoma
Acute lymphoblastic leukemia
Acute Promyelocytic Leukemia
Diffuse Large Cell Lymphoma
  • Enlarged painful lymph node
  • Neurological or gastrointestinal manifestations
  • History of environmental and/or infectious disease exposure
  • Lymphadenopathy
  • Splenomegaly
  • Low-grade fever
  • Pedal edema:

Differential for Eosinophilia

Pathophysiology Symptoms History Physical Examination Laboratory Findings
Parasitic Infections Vary depending on the organism
  • GI
  • STD
  • Neurological
  • Swollen lymph nodes and muscle aches or pains
  • History of travel
  • Rash
  • Fever
  • Lymphadenopathy
  • Ulcers
  • +Stool examination
  • + Serologic testing
  • Urinalysis
Allergy/ Atopic Diseases
  • Allergic hypersensitivity
    • IgE stimulation
Systemic anaphylaxis
  • Reaction occurs within minutes
  • Leading to symptomatology such as
    • Acute asthma
    • Laryngeal edema
    • Diarrhea
    • Urticaria
    • Shock.
  • Classic examples are penicillin allergy and bee sting allergy.

Local anaphylaxis (atopy)

  • About 10% of people have "atopy" and are easily sensitized to allergens that cause a localized reaction when inhaled or ingested.
    • Hay fever
    • Hives, asthma.
  • Classic examples are food allergies and hay fever to ragweed pollen
  • History consistent with allergy and specific allergens
  • Increase in eosinophils
  • Serum tryptase positive reaction
  • Testing for specific IgE antigen.
Hypereosinophilic syndromes (HES)
  • Activation of tyrosine kinases
    • Clonal eosinophilic proliferation
    • Overproduction of eosinophilopoietic cytokines.
Acute myelogenous leukemias
  • Mutation of myeloblast freezes the cell in its immature state and prevent differentiation.
  • Persistent or frequent infections.
  • Anemia leads to fatigue, paleness, and shortness of breath.
  • Thrombocytopenia leads to bruising or bleeding with minor trauma.
  • Bone tenderness
  • Skin manifestations
  • Immature Myeloblasts on blood smear
  • Flow cytometry
  • +Aur Rods
Hodgkin's, T- and B-cell lymphomas)
  • Reed-Sternberg cell
    • B-cell origin
    • CD30 (Ki-1) and CD15 (Leu-M1) antigens
  • Painless localized peripheral lymphadenopathy
  • B symptoms
  • Presence or absence, duration, and severity of other associated systemic symptoms.
  • History of previous malignancy (including other lymphomas)
  • Prior treatment with chemotherapy or radiotherapy
  • Previous immunosuppressive illness
  • Family history of HL or other lymphoproliferative, myeloproliferative, or tissue malignancies.
  • Palpable, painless lymphadenopathy
  • Superior vena cava
  • Central nervous system (CNS) symptoms
  • Paraneoplastic syndromes including
    • Cerebellar degeneration
    • Neuropathy
    • Guillain-Barre syndrome
    • Multifocal leukoencephalopathy
  • Fine-needle aspiration
    • Mononucleate and binucleate Reed-Sternberg cells in a background of inflammatory cells
  • Lactate dehydrogenase (LDH) may be increased.
  • ESR elevated
  • Serum creatinine elevated in nephrotic syndrome.
  • Alkaline phosphatase (ALP) increased
  • Hypercalcemia, hypernatremia, and hypoglycemia.
Churg-Strauss

(Eosinophilic granulomatosis with polyangiitis)

  • History of allergy
  • Skin involvement (60%)
  • Nasal polyposis
  • Peripheral neuropathy
Systemic mastocytosis
  • Infiltration of bone marrow by mast cell affecting the peripheral blood and coagulation system.
  • The neoplastic clone of mast cells express abnormal cell surface markers CD25 and/or CD2.
  • GI
  • Cutaneous
  • Urticaria pigmentosa
  • Musculoskeletal
  • Idiopathic and/or recurrent anaphylactoid reactions
History of/ Associated with
  • Hypereosinophilic syndrome
  • Castleman disease
  • Monoclonal gammopathy
  • Hairy cell leukemia
  • Non-Hodgkin lymphoma
  • Polycythemia vera
  • Primary thrombocythemia
  • Signs of anemia,
  • Hepatoslenomegaly
  • Lymphadenopathy
  • Urticaria
    • Flushing
  • Osteolysis
  • CBC
    • Eosinophilia
    • Basophilia
    • Thrombocytosis
    • Monocytosis
  • Total–to–beta-tryptase ratio greater than 20:1 is suggestive.
  • CD117 positive and CD25 and/or CD2 positive.
  • Abnormal mast cells.
    • Larger than normal mast cells
    • Irregularly shaped nuclear outlines
    • Less densely packed mast cell granules